CDX2 as a Prognostic Biomarker in Colon Cancer REPLY

被引：0
|
作者：
Dalerba, Piero [1 ]
Sahoo, Debashis [2 ]
Clarke, Michael F. [3 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Stanford Univ, Stanford, CA 94305 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 22期
关键词：
COLORECTAL-CANCER; EXPRESSION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2184 / 2184
页数：1
相关论文
共 50 条
  • [1] CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
    Dalerba, Piero
    Sahoo, Debashis
    Paik, Soonmyung
    Guo, Xiangqian
    Yothers, Greg
    Song, Nan
    Wilcox-Fogel, Nate
    Forgo, Erna
    Rajendran, Pradeep S.
    Miranda, Stephen P.
    Hisamori, Shigeo
    Hutchison, Jacqueline
    Kalisky, Tomer
    Qian, Dalong
    Wolmark, Norman
    Fisher, George A.
    van de Rijn, Matt
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03) : 211 - 222
  • [2] Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer
    Ilie-Petrov, Andreea-Corina
    Cristian, Daniel-Alin
    Grama, Florin Andrei
    Chitul, Andrei
    Blajin, Angela
    Popa, Andrei
    Mandi, Draga-Maria
    Welt, Luminita
    Bara, Marina Alina
    Vrincianu, Rares
    Ardeleanu, Carmen Maria
    DIAGNOSTICS, 2024, 14 (10)
  • [3] CDX2 Is a Prognostic Biomarker for Unresectable Metastatic Colorectal Cancer
    Mukohyama, Junko
    Agawa, Kyosuke
    Yamashita, Kimihiro
    Matsuda, Takeru
    Shinoda, Masahiro
    Itano, Osamu
    Kakeji, Yoshihiro
    ANTICANCER RESEARCH, 2023, 43 (08) : 3763 - 3767
  • [4] The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer
    Chan, Wei Yen
    Chua, Wei
    Wilkinson, Kate
    Epitakaduwa, Chandika
    Mandaliya, Hiren
    Descallar, Joseph
    Roberts, Tara Laurine
    Becker, Therese Maria
    Ng, Weng
    Lee, Cheok Soon
    Lim, Stephanie Hui-Su
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [5] Prognostic impact of CDX2 in colorectal cancer
    Yuan, Lan-Ting Emily
    Ting, Kai-Ting
    Huang, Chih-Wei Dave
    Tsai, Ching-Yang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 518 - 518
  • [6] CDX2 as a prognostic marker in gastric cancer
    Masood, Muhammad Adnan
    Loya, Asif
    Yusuf, Muhammed Aasim
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02) : 197 - 200
  • [7] Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
    Hansen, Torben Frostrup
    Kjaer-Frifeldt, Sanne
    Eriksen, Ann Christina
    Lindebjerg, Jan
    Jensen, Lars Henrik
    Sorensen, Flemming Brandt
    Jakobsen, Anders
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 1367 - 1373
  • [8] CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
    Pilati, C.
    Taieb, J.
    Balogoun, R.
    Marisa, L.
    de Reynies, A.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 1032 - 1035
  • [9] SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer
    Ma, Changqing
    Olevian, Dane
    Miller, Caitlyn
    Herbst, Cameron
    Jayachandran, Priya
    Kozak, Margaret M.
    Chang, Daniel T.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2019, 32 (08) : 1217 - 1231
  • [10] CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer
    Cecchini, Matthew J.
    Walsh, Joanna C.
    Parfitt, Jeremy
    Chakrabarti, Subrata
    Correa, Rohann J.
    MacKenzie, Mary J.
    Driman, David K.
    HUMAN PATHOLOGY, 2019, 90 : 70 - 79
12345